RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?. (2019). Mediterranean Journal of Hematology and Infectious Diseases, 11(1), e2019024. https://doi.org/10.4084/mjhid.2019.024